메뉴 건너뛰기




Volumn 107, Issue 7, 2012, Pages 1107-1115

Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies

Author keywords

chemotherapy; mesothelioma; non small cell lung cancer; prognosis; T cells

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; PACLITAXEL; PEMETREXED;

EID: 84866920006     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.362     Document Type: Article
Times cited : (57)

References (53)
  • 1
    • 0030671044 scopus 로고    scopus 로고
    • Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: A three-colour cytometric analysis
    • Afeltra A, Galeazzi M, Sebastiani GD, Ferri GM, Caccavo D, Addessi MA, Marcolongo R, Bonomo L (1997) Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: a three-colour cytometric analysis. Int J Exp Pathol 78(5): 331-336
    • (1997) Int J Exp Pathol , vol.78 , Issue.5 , pp. 331-336
    • Afeltra, A.1    Galeazzi, M.2    Sebastiani, G.D.3    Ferri, G.M.4    Caccavo, D.5    Addessi, M.A.6    Marcolongo, R.7    Bonomo, L.8
  • 3
    • 77955483885 scopus 로고    scopus 로고
    • Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma
    • Anraku M, Tagawa T, Wu L, Yun Z, Keshavjee S, Zhang L, Johnston MR, de Perrot M (2010) Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma. J Immunol 185(2): 956-966
    • (2010) J Immunol , vol.185 , Issue.2 , pp. 956-966
    • Anraku, M.1    Tagawa, T.2    Wu, L.3    Yun, Z.4    Keshavjee, S.5    Zhang, L.6    Johnston, M.R.7    De Perrot, M.8
  • 4
    • 0019475622 scopus 로고
    • Mathematic coupling of data: A common source of error
    • Archie Jr JP (1981) Mathematic coupling of data: a common source of error. Ann Surg 193(3): 296-303
    • (1981) Ann Surg , vol.193 , Issue.3 , pp. 296-303
    • Archie Jr., J.P.1
  • 5
    • 67649422143 scopus 로고    scopus 로고
    • Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy
    • Bellone G, Novarino A, Vizio B, Brondino G, Addeo A, Prati A, Giacobino A, Campra D, Fronda GR, Ciuffreda L (2009) Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy. Int J Oncol 34(6): 1701-1715
    • (2009) Int J Oncol , vol.34 , Issue.6 , pp. 1701-1715
    • Bellone, G.1    Novarino, A.2    Vizio, B.3    Brondino, G.4    Addeo, A.5    Prati, A.6    Giacobino, A.7    Campra, D.8    Fronda, G.R.9    Ciuffreda, L.10
  • 7
    • 1342267614 scopus 로고    scopus 로고
    • Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
    • Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15(2): 257-260
    • (2004) Ann Oncol , vol.15 , Issue.2 , pp. 257-260
    • Byrne, M.J.1    Nowak, A.K.2
  • 11
    • 0033849171 scopus 로고    scopus 로고
    • Prognostic factors for malignant mesothelioma in 142 patients: Validation of CALGB and EORTC prognostic scoring systems
    • Edwards JG, Abrams KR, Leverment JN, Spyt TJ, Waller DA, O'Byrne KJ (2000) Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax 55(9): 731-735
    • (2000) Thorax , vol.55 , Issue.9 , pp. 731-735
    • Edwards, J.G.1    Abrams, K.R.2    Leverment, J.N.3    Spyt, T.J.4    Waller, D.A.5    O'Byrne, K.J.6
  • 13
    • 68749098345 scopus 로고    scopus 로고
    • A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: A combined analysis of 10 EORTC trials
    • Francart J, Vaes E, Henrard S, Legrand C, Baas P, Gaafar R, van Meerbeeck JP, Sylvester R, Robert A (2009) A prognostic index for progression-free survival in malignant mesothelioma with application to the design of phase II trials: a combined analysis of 10 EORTC trials. Eur J Cancer 45(13): 2304-2311
    • (2009) Eur J Cancer , vol.45 , Issue.13 , pp. 2304-2311
    • Francart, J.1    Vaes, E.2    Henrard, S.3    Legrand, C.4    Baas, P.5    Gaafar, R.6    Van Meerbeeck, J.P.7    Sylvester, R.8    Robert, A.9
  • 14
    • 78049479930 scopus 로고    scopus 로고
    • Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms
    • Fridlender ZG, Sun J, Singhal S, Kapoor V, Cheng G, Suzuki E, Albelda SM (2010) Chemotherapy delivered after viral immunogene therapy augments antitumor efficacy via multiple immune-mediated mechanisms. Mol Ther 18(11): 1947-1959
    • (2010) Mol Ther , vol.18 , Issue.11 , pp. 1947-1959
    • Fridlender, Z.G.1    Sun, J.2    Singhal, S.3    Kapoor, V.4    Cheng, G.5    Suzuki, E.6    Albelda, S.M.7
  • 15
    • 0021212003 scopus 로고
    • Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67
    • Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133(4): 1710-1715
    • (1984) J Immunol , vol.133 , Issue.4 , pp. 1710-1715
    • Gerdes, J.1    Lemke, H.2    Baisch, H.3    Wacker, H.H.4    Schwab, U.5    Stein, H.6
  • 18
    • 0034655122 scopus 로고    scopus 로고
    • Cutting edge: Increased expression of Bcl-2 in antigen-specific memory CD8 + T cells
    • Grayson JM, Zajac AJ, Altman JD, Ahmed R (2000) Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8 + T cells. J Immunol 164(8): 3950-3954
    • (2000) J Immunol , vol.164 , Issue.8 , pp. 3950-3954
    • Grayson, J.M.1    Zajac, A.J.2    Altman, J.D.3    Ahmed, R.4
  • 19
    • 0031887839 scopus 로고    scopus 로고
    • Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B
    • Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ (1998) Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113(3): 723-731
    • (1998) Chest , vol.113 , Issue.3 , pp. 723-731
    • Herndon, J.E.1    Green, M.R.2    Chahinian, A.P.3    Corson, J.M.4    Suzuki, Y.5    Vogelzang, N.J.6
  • 20
    • 42249115188 scopus 로고    scopus 로고
    • Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3 + regulatory T cells
    • Ladoire S, Arnould L, Apetoh L, Coudert B, Martin F, Chauffert B, Fumoleau P, Ghiringhelli F (2008) Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3 + regulatory T cells. Clin Cancer Res 14(8): 2413-2420
    • (2008) Clin Cancer Res , vol.14 , Issue.8 , pp. 2413-2420
    • Ladoire, S.1    Arnould, L.2    Apetoh, L.3    Coudert, B.4    Martin, F.5    Chauffert, B.6    Fumoleau, P.7    Ghiringhelli, F.8
  • 21
    • 18344375283 scopus 로고    scopus 로고
    • Immunotherapy and chemotherapy - A practical partnership
    • Lake RA, Robinson BW (2005) Immunotherapy and chemotherapy-a practical partnership. Nat Rev Cancer 5(5): 397-405
    • (2005) Nat Rev Cancer , vol.5 , Issue.5 , pp. 397-405
    • Lake, R.A.1    Robinson, B.W.2
  • 23
    • 0035328683 scopus 로고    scopus 로고
    • Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
    • Machiels JP, Reilly RT, Emens LA, Ercolini AM, Lei RY, Weintraub D, Okoye FI, Jaffee EM (2001) Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res 61(9): 3689-3697
    • (2001) Cancer Res , vol.61 , Issue.9 , pp. 3689-3697
    • MacHiels, J.P.1    Reilly, R.T.2    Emens, L.A.3    Ercolini, A.M.4    Lei, R.Y.5    Weintraub, D.6    Okoye, F.I.7    Jaffee, E.M.8
  • 24
    • 18744435046 scopus 로고    scopus 로고
    • Restoration of T-cell homeostasis after T-cell depletion
    • Mackall CL, Hakim FT, Gress RE (1997) Restoration of T-cell homeostasis after T-cell depletion. Semin Immunol 9(6): 339-346
    • (1997) Semin Immunol , vol.9 , Issue.6 , pp. 339-346
    • MacKall, C.L.1    Hakim, F.T.2    Gress, R.E.3
  • 30
    • 0038326676 scopus 로고    scopus 로고
    • Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells
    • Nowak AK, Lake RA, Marzo AL, Scott B, Heath WR, Collins EJ, Frelinger JA, Robinson BW (2003) Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells. J Immunol 170(10): 4905-4913
    • (2003) J Immunol , vol.170 , Issue.10 , pp. 4905-4913
    • Nowak, A.K.1    Lake, R.A.2    Marzo, A.L.3    Scott, B.4    Heath, W.R.5    Collins, E.J.6    Frelinger, J.A.7    Robinson, B.W.8
  • 31
  • 32
    • 0037089545 scopus 로고    scopus 로고
    • Gemcitabine exerts a selective effect on the humoral immune response: Implications for combination chemo-immunotherapy
    • Nowak AK, Robinson BW, Lake RA (2002) Gemcitabine exerts a selective effect on the humoral immune response: implications for combination chemo-immunotherapy. Cancer Res 62(8): 2353-2358
    • (2002) Cancer Res , vol.62 , Issue.8 , pp. 2353-2358
    • Nowak, A.K.1    Robinson, B.W.2    Lake, R.A.3
  • 33
    • 0042591416 scopus 로고    scopus 로고
    • Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors
    • Nowak AK, Robinson BW, Lake RA (2003) Synergy between chemotherapy and immunotherapy in the treatment of established murine solid tumors. Cancer Res 63(15): 4490-4496
    • (2003) Cancer Res , vol.63 , Issue.15 , pp. 4490-4496
    • Nowak, A.K.1    Robinson, B.W.2    Lake, R.A.3
  • 36
    • 22244489353 scopus 로고    scopus 로고
    • Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas
    • Plate JMD, Plate AAE, Shott S, Bograd S, Harris JE (2005) Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas. Cancer Immunol Immunother 54(9): 915-925
    • (2005) Cancer Immunol Immunother , vol.54 , Issue.9 , pp. 915-925
    • Jmd, P.1    Aae, P.2    Shott, S.3    Bograd, S.4    Harris, J.E.5
  • 37
    • 0031863680 scopus 로고    scopus 로고
    • B cells inhibit induction of T cell-dependent tumor immunity
    • Qin Z, Richter G, Schuler T, Ibe S, Cao X, Blankenstein T (1998) B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 4(5): 627-630
    • (1998) Nat Med , vol.4 , Issue.5 , pp. 627-630
    • Qin, Z.1    Richter, G.2    Schuler, T.3    Ibe, S.4    Cao, X.5    Blankenstein, T.6
  • 38
    • 79959733137 scopus 로고    scopus 로고
    • Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells
    • Rettig L, Seidenberg S, Parvanova I, Samaras P, Knuth A, Pascolo S (2011) Gemcitabine depletes regulatory T-cells in human and mice and enhances triggering of vaccine-specific cytotoxic T-cells. Int J Cancer 129(4): 832-838
    • (2011) Int J Cancer , vol.129 , Issue.4 , pp. 832-838
    • Rettig, L.1    Seidenberg, S.2    Parvanova, I.3    Samaras, P.4    Knuth, A.5    Pascolo, S.6
  • 42
    • 0034332403 scopus 로고    scopus 로고
    • Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo
    • Schluns KS, Kieper WC, Jameson SC, Lefrancois L (2000) Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 1(5): 426-432
    • (2000) Nat Immunol , vol.1 , Issue.5 , pp. 426-432
    • Schluns, K.S.1    Kieper, W.C.2    Jameson, S.C.3    Lefrancois, L.4
  • 44
    • 85027957593 scopus 로고    scopus 로고
    • Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
    • Sistigu A, Viaud S, Chaput N, Bracci L, Proietti E, Zitvogel L (2011) Immunomodulatory effects of cyclophosphamide and implementations for vaccine design. Semin Immunopathol 33(4): 369-383
    • (2011) Semin Immunopathol , vol.33 , Issue.4 , pp. 369-383
    • Sistigu, A.1    Viaud, S.2    Chaput, N.3    Bracci, L.4    Proietti, E.5    Zitvogel, L.6
  • 45
    • 0037124366 scopus 로고    scopus 로고
    • Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8 + cells but are not required for memory phenotype CD4 + cells
    • Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD (2002) Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8 + cells but are not required for memory phenotype CD4 + cells. J Exp Med 195(12): 1523-1532
    • (2002) J Exp Med , vol.195 , Issue.12 , pp. 1523-1532
    • Tan, J.T.1    Ernst, B.2    Kieper, W.C.3    Leroy, E.4    Sprent, J.5    Surh, C.D.6
  • 46
  • 48
    • 67349250111 scopus 로고    scopus 로고
    • Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: A role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
    • van der Most RG, Currie AJ, Mahendran S, Prosser A, Darabi A, Robinson BW, Nowak AK, Lake RA (2009) Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy. Cancer Immunol Immunother 58(8): 1219-1228
    • (2009) Cancer Immunol Immunother , vol.58 , Issue.8 , pp. 1219-1228
    • Van Der Most, R.G.1    Currie, A.J.2    Mahendran, S.3    Prosser, A.4    Darabi, A.5    Robinson, B.W.6    Nowak, A.K.7    Lake, R.A.8
  • 51
    • 38949216307 scopus 로고    scopus 로고
    • Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens
    • Wijayahadi N, Haron MR, Stanslas J, Yusuf Z (2007) Changes in cellular immunity during chemotherapy for primary breast cancer with anthracycline regimens. J Chemother 19(6): 176-723
    • (2007) J Chemother , vol.19 , Issue.6 , pp. 176-723
    • Wijayahadi, N.1    Haron, M.R.2    Stanslas, J.3    Yusuf, Z.4
  • 52
    • 34848879000 scopus 로고    scopus 로고
    • Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth
    • Zhong H, Han B, Tourkova IL, Lokshin A, Rosenbloom A, Shurin MR, Shurin GV (2007) Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth. Clin Cancer Res 13(18): 5455-5462
    • (2007) Clin Cancer Res , vol.13 , Issue.18 , pp. 5455-5462
    • Zhong, H.1    Han, B.2    Tourkova, I.L.3    Lokshin, A.4    Rosenbloom, A.5    Shurin, M.R.6    Shurin, G.V.7
  • 53
    • 77953701142 scopus 로고    scopus 로고
    • Immunogenic tumor cell death for optimal anticancer therapy: The calreticulin exposure pathway
    • Zitvogel L, Kepp O, Senovilla L, Menger L, Chaput N, Kroemer G (2010) Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res 16(12): 3100-3104
    • (2010) Clin Cancer Res , vol.16 , Issue.12 , pp. 3100-3104
    • Zitvogel, L.1    Kepp, O.2    Senovilla, L.3    Menger, L.4    Chaput, N.5    Kroemer, G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.